Tocqueville Asset Management L.P. Reduces Holdings in Colgate-Palmolive

Tocqueville Asset Management L.P. has reduced its stake in Colgate-Palmolive (NYSE:CL - Free Report) by 4.9% during the fourth quarter of the year, based on its latest 13F filing with the Securities and Exchange Commission (SEC). Following the sale of 29,379 shares in this period, Tocqueville now owns a total of 575,090 shares in the company. This investment accounts for 0.8% of Tocqueville's investment portfolio, ranking it as the 25th largest holding within the fund.

According to its most recent SEC filing, Tocqueville's stake in Colgate-Palmolive is valued at approximately $52,281,000, representing about 0.07% of the company’s total equity.

Additionally, several other institutional investors and hedge funds have recently made adjustments to their positions in Colgate-Palmolive. For instance, Kohmann Bosshard Financial Services LLC acquired a new stake worth about $26,000, while Centricity Wealth Management LLC purchased shares valued around $27,000 in the same period. Union Bancaire Privee UBP SA also established a new stake worth approximately $32,000, along with Briaud Financial Planning Inc., which bought shares in the same price range. Wintrust Investments LLC also added a new stake valued at about $33,000. Notably, institutional investors hold about 80.41% of Colgate-Palmolive's shares.

Stock Performance Overview

Colgate-Palmolive’s shares were priced at $89.80 at the start of trading on Monday. The company has a fifty-day moving average price of $89.02 and a two-hundred-day moving average of $94.67. The financial standings indicate a debt-to-equity ratio of 13.40, a current ratio of 0.92, and a quick ratio of 0.58. Over the past year, the company’s shares have experienced a low of $85.32 and a high of $109.30. Currently, Colgate-Palmolive has a market cap of $72.87 billion, a price-to-earnings (P/E) ratio of 25.51, and a PEG ratio of 4.20, along with a beta of 0.40.

Recent Earnings Report

The most recent quarterly earnings for Colgate-Palmolive were announced on January 31st, where the company reported earnings of $0.91 per share, which surpassed the consensus estimate of $0.90 by $0.01. The company recorded a net margin of 14.38% and a remarkable return on equity of 477.77%. This marks an increase compared to the previous year, which reported earnings of $0.87 per share. Analysts project that Colgate-Palmolive will achieve earnings-per-share (EPS) of $3.75 for the current fiscal year.

Analyst Ratings Update

In terms of recent analyst ratings, several research analysts have shared their insights regarding Colgate-Palmolive's shares. JPMorgan Chase & Co. has raised their price target for Colgate-Palmolive from $97.00 to $99.00 and has assigned an 'overweight' rating in their latest research note. Raymond James has reiterated an 'outperform' rating while adjusting their price objective down to $105.00 from $110.00. Similarly, TD Cowen has also lowered their price target from $110.00 to $100.00 and maintained a 'buy' rating for the shares. However, Wells Fargo & Company has decreased their price target from $92.00 to $83.00 and given the company an 'underweight' rating; Barclays also has lowered their price target from $96.00 to $83.00 while maintaining an 'equal weight' status. According to MarketBeat, one analyst rates the stock as a sell, while ten analysts suggest holding it, and eleven recommend buying it, reflecting an average rating of 'Hold' with a consensus price target of $101.72.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, along with its subsidiaries, manufactures and offers consumer products both in the U.S. and globally. The business operates through two primary segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment includes offerings such as toothpaste, toothbrushes, mouthwash, various soaps, shampoos, conditioners, deodorants, antiperspirants, skin health products, dishwashing detergents, and other household cleaners.

investment, stocks, holdings